Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when MLAB files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Departure of CEO (new) — The CEO is departing the company, which represents a significant leadership change.
Mesa Labs CEO Gary Owens departing April 13; receives severance and pro-rated equity
Filed March 23, 2026 · Period ending March 20, 2026 · ~1 min read
Key Changes
-
high
CEO Gary Owens is leaving his role effective April 13, 2026, and will remain in a non-executive capacity through June 22, 2026 to assist with the transition to his successor.
Item 5.02 verify on EDGAR → -
medium
Owens will receive severance pay and benefits as if terminated without cause, plus a pro-rated portion of his June 2025 performance stock units vesting at the lower of target or actual performance.
Transition Agreement verify on EDGAR → -
medium
Owens resigned from the board of directors effective March 20, 2026. The company states the resignation is not due to any disagreement on operations, policies, or practices.
Item 5.02 verify on EDGAR →
Summary
Mesa Laboratories announced that President and CEO Gary Owens is departing effective April 13, 2026. Owens will remain with the company in a non-executive capacity through June 22, 2026 to facilitate the transition to his successor. He also resigned from the board of directors effective March 20, 2026, though the company explicitly states this was not due to any disagreement about company operations or strategy.
Under the transition agreement, Owens will receive severance pay and benefits consistent with a without-cause termination, plus a pro-rated portion of his June 2025 performance stock unit award. The PSUs will vest at the lower of target or actual performance at the end of the performance period.
For retail investors, CEO departures often signal strategic shifts or operational challenges, though the amicable language suggests a planned transition rather than a crisis. Investors should watch for the announcement of Owens' successor and any strategic direction changes the new CEO may bring. The company's performance over the next two quarters will be critical to assess whether this leadership change impacts operational momentum or customer relationships.
Section-by-Section Diff
Event · Item 9.01 — Financial Statements and Exhibits
Mesa Labs disclosed a transition agreement with Gary Owens dated March 20, 2026.
Added in current filing · verify on EDGAR →
Transition Agreement, dated as of March 20, 2026, by and among Mesa Laboratories, Inc. and Gary Owens.
Mesa Laboratories entered into a transition agreement with Gary Owens on March 20, 2026.Investors should review the full exhibit for compensation, severance, non-compete, or other material terms.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify